Back to directory
A New Age of Oxygen Equilibrium
AustinFounded 202215 employees
Medical DevicesHospitals & Health IT
See something off about this company?
A New Age of Oxygen Equilibrium
We have developed a next-generation blood testing instrument for measuring Oxygen-hemoglobin Dissociation Curve and MetHemoglobin - 10 times more precise, 3 times faster than current market devices, and requires only a drop of blood. We aim to radically streamline pharma R&D, Clinical, Chronic, and Emergency Medical Care, helping improve outcomes for patients suffering from blood disorders worldwide. In addition to our focus on healthcare, we also target Military, Athletic & High-Altitude Training, Animal Testing & Research, Field Testing, and other markets.
See something off about this company?
Olek Shestakov
founder
The Oxygen-Hemoglobin Equilibrium Curve (OEC) is a fundamental measurement for understanding how a patient’s blood carries and releases oxygen. This test is critically important for establishing therapeutic processes for many disorders, like sickle cell anemia and pulmonary diseases. Currently-available OEC blood testing devices have many shortcomings as a result of the lack of major development or advancement in the last two decades. They cannot support current market needs due to large blood sample requirements, complex supply chains, lengthy testing time, messy blood spills, frequent calibration and maintenance, and difficult operation.
We are post-revenue ($96k in sales), our product is ready and in the process of FDA & EMA certification. Our foundational client is PFIZER, and we are in an extensive remote and on-site pilot program with them. We sell instruments/services for R&D purposes pre-FDA approval, and are actively expanding our referrals & pipeline.